ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,310Medicare Part D Prescriptions Filled, Including Refills

Rank: 187 out of 890

$681K Total Retail Price of All Prescriptions

Rank: 151 out of 890

386 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

17% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,594 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 444 395 1 7
LEVOTHYROXINE SODIUM 303 216 2 2
NAMENDA 302 268 3 36
POLYETHYLENE GLYCOL 3350 280 205 4 67
AMLODIPINE BESYLATE 270 168 5 1
OMEPRAZOLE 248 195 6 8
SIMVASTATIN 236 157 7 5
DONEPEZIL HCL 218 215 8 30
POTASSIUM CHLORIDE 218 180 8 11
QUETIAPINE FUMARATE 177 115 10 73
NOVOLIN R 173 101 11 153
METFORMIN HCL 169 103 12 6
HYDROCODONE-ACETAMINOPHEN 166 128 S3 13 3
WARFARIN SODIUM 160 148 14 24
VENLAFAXINE HCL ER 156 128 15 114
TRAMADOL HCL 155 122 16 16
GABAPENTIN 144 95 17 12
DIGOXIN 143 143 18 65
CITALOPRAM HBR 143 128 18 20
ENALAPRIL MALEATE 142 91 20 56
METOPROLOL SUCCINATE 140 114 21 17
CYMBALTA 137 102 22 45
LISINOPRIL 133 93 23 4
CARVEDILOL 132 106 24 22
LANTUS 128 98 25 50
MIRTAZAPINE 126 104 26 82
NEXIUM 114 112 27 14
AZITHROMYCIN 112 70 28 37
TAMSULOSIN HCL 111 84 29 32
GLIMEPIRIDE 97 35 30 27
LACTULOSE 88 48 31 112
EXELON 88 88 31 113
NOVOLIN 70-30 85 56 33 199
ESCITALOPRAM OXALATE 83 55 34 51
CIPROFLOXACIN HCL 81 75 35 58
HYDROCHLOROTHIAZIDE 76 35 36 9
RISPERIDONE 75 43 37 78
CLONIDINE HCL 73 63 38 35
SANTYL 72 48 39 246
ADVAIR DISKUS 71 67 40 52
SERTRALINE HCL 69 65 41 26
ALBUTEROL SULFATE 67 56 42 162
PANTOPRAZOLE SODIUM 66 48 43 34
SEROQUEL 66 43 43 167
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 53 45 76
ALENDRONATE SODIUM 64 52 46 38
ATENOLOL 64 64 46 23
ISOSORBIDE MONONITRATE ER 64 58 46 60
OXYBUTYNIN CHLORIDE 63 51 49 139
TRAZODONE HCL 62 54 50 40
METOPROLOL TARTRATE 61 59 51 15
CLOPIDOGREL 59 40 52 28
MELOXICAM 59 55 52 18
GEMFIBROZIL 59 37 52 103
GLIPIZIDE 59 40 52 62
DIOVAN 58 52 56 33
PAROXETINE HCL 56 22 57 68
JANTOVEN 56 56 57 169
MEGESTROL ACETATE 56 42 R 57 92
HUMULIN R 55 36 60 260
LEVETIRACETAM 53 24 61 137
ALLOPURINOL 52 41 62 31
HUMULIN 70-30 51 34 63 241
DIVALPROEX SODIUM ER 50 14 64 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.